Companies / Flexion Therapeutics Inc
Flexion Therapeutics Inc
FLXNCIK 1419600
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Nov 19, 2021 | Colella Samuel D Director | Other Sold to issuer | Common Stock | $8.45M | -994K -100.00% | 0 | low |
| Nov 19, 2021 | Colella Samuel D Director | Other Sold to issuer | Common Stock | $3.30M | -389K -100.00% | 0 | low |
| Nov 19, 2021 | Clayman Michael D. CEO | Other Sold to issuer | Common Stock | $3.30M | -389K -100.00% | 0 | low |
| Nov 19, 2021 | Clayman Michael D. CEO | Other Sold to issuer | Common Stock | $3.18M | -374K -100.00% | 0 | low |
| Nov 19, 2021 | Clayman Michael D. CEO | Other Sold to issuer | Common Stock | $2.85M | -335K -100.00% | 0 | low |
| Nov 19, 2021 | Willwerth Christina Executive | Other Sold to issuer | Common Stock | $1.20M | -141K -100.00% | 0 | low |
| Nov 19, 2021 | Wentworth Kerry Executive | Other Sold to issuer | Common Stock | $1.20M | -141K -100.00% | 0 | low |
| Nov 19, 2021 | Levine Mark S. Executive | Other Sold to issuer | Common Stock | $1.13M | -133K -100.00% | 0 | low |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| FLXN | fund | 44053A523 |